• jump to the main content
  • jump to the bottom of the page
  • News
  • Podcasts
  • Activities
  • Location and contact
  • Español Contenido en español
  • Català Contingut en català
  • English Current language Spanish
COLLABORATE El Meu Clínic .This link opens in a new tab.
  • Español Contenido en español
  • Català Contingut en català
  • English Current language Spanish
Idibaps logo
COLLABORATE El Meu Clínic .This link opens in a new tab.
  • Healthcare
    • Diseases, symptoms and health conditions
    • Tests and procedures
    • Be healthy
    • Urgencies
    • Patients and companions
    • Assistive Devices
    • Organizational structure
  • Research
    • Home
    • About research
    • Areas and Programmes
    • Core Facilities
    • Knowledge and Technology Transfer
    • Work at Idibaps
  • Teaching
    • Teaching
    • Students
    • Residents
    • SIMClínic
    • Training stays
    • Training for professionals
  • Patients and companions
  • About the Clinic
  • News
  • Podcasts
  • Activities
  • Location and contact
  • Español Contenido en español
  • Català Contingut en català
  • English Current language Spanish
COLLABORATE El Meu Clínic .This link opens in a new tab.
  • Español Contenido en español
  • Català Contingut en català
  • English Current language Spanish
Enter your search and press enter or click on search
Navigation thread
  • Home
  • Organizational structure
  • Institute of Nephrology and Urology
  • Nephrology and Renal Transplant Service
  • News
  • Nephrology and Renal Transplant Service

Service News from Nephrology and Renal Transplant

January 13 2021

What is the quality of life of kidney donors after one year?

The majority of kidney donors believe that it was worth going through the process of donation, and would repeat it if necessary. This study, coor1

July 29 2020

Treatment with tocilizumab in patients with kidney transplant reduces mortality from COVID-19

In a retrospective study with 80 kidney transplant patients with COVID-19, treatment with tocilizumab demonstrates a decrease in one of the inflammat1

November 11 2019

New technique to identify a cause that is common to diseases related to thrombotic microangiopathies for which there is a treatment

Researchers of the Hospital Clínic-IDIBAPS and the Josep Carreras Leukemia Research Institute have developed a new technique that allows detecting an1

navigation between pages below

go to the first page previous page
current page 4 / de 4
  • page1
  • page2
  • page3
  • page4 , current page.

Subscribe to the Newsletter of Clínic

Receive the latest news from our institution directly to your email.

(*) Mandatory fields

Thanks for your subscription!

We have received your information. Check your inbox, in a few moments you will receive a confirmation email.

An error has occurred and we have not been able to send your data, please try again later.
  • Healthcare

    • Diseases, symptoms and health conditions
    • Tests and procedures
    • Be healthy
    • Urgencies
    • Patients and companions
    • Work with Clínic
  • Research

    • Home
    • About research
    • Areas and Programmes
    • Core Facilities
    • Work with IDIBAPS
  • Teaching

    • Teaching
    • Students
    • Residents
    • Training stays
    • Training for professionals
  • ENS Certificate

    • ENS Certificate .This link opens in a new tab.
  • Cookies policy
  • Profile of the contracting party
  • Legal Notice
  • Data protection
  • Transparency portal
  • Privacy policy
  • Complaint channel
  • Español Contenido en español
  • Català Contingut en català
  • English Current language Spanish
© Clínic Barcelona 2026